Idiotypic-susceptible Alzheimer’s disease: a clinically relevant, neurofibrillary tangle subtype - Scorecard - MDSpire

Idiotypic-susceptible Alzheimer’s disease: a clinically relevant, neurofibrillary tangle subtype

  • By

  • John L. Robinson

  • Helen Cai

  • Nicholas J. Loh

  • Omar Vazquez

  • Zahra Khodakaramimaghsoud

  • EunRan Suh

  • Vivianna M. Van Deerlin

  • Paul A. Yushkevich

  • Dawn Mechanic-Hamilton

  • Sharon X. Xie

  • Daniel T. Ohm

  • David A. Wolk

  • David J. Irwin

  • Jeffrey S. Phillips

  • Edward B. Lee

  • May 2, 2026

  • 0 min

Share

Clinical Scorecard: Alzheimer's Disease with Idiotypic Vulnerability: A Clinically Significant Subtype Characterized by Neurofibrillary Tangles

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients diagnosed with Alzheimer's Disease, including early-onset, late-onset, and non-amnestic variants.
Care Setting

Key Highlights

  • Heterogeneity in Alzheimer's Disease identified through distinct tau subtypes and their clinical implications.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis should be made through consensus by expert clinicians per published criteria, including NIA-AA.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Treatment approaches may need to be tailored based on the identified tau subtype, including specific pharmacological and non-pharmacological interventions.

        Clinical Best Practices

        • Utilize tau-PET imaging for subtype identification.
        • Incorporate cognitive assessments across various domains for comprehensive evaluation.
        • Engage in multidisciplinary care approaches for managing diverse clinical presentations.
        • Consider genetic counseling for patients with MAPT H1H1 haplotype.

        References

        Original Source(s)

        Idiotypic-susceptible Alzheimer’s disease: a clinically relevant, neurofibrillary tangle subtype

        • by John L. Robinson, Helen Cai, Nicholas J. Loh, Omar Vazquez, Zahra Khodakaramimaghsoud, EunRan Suh, Vivianna M. Van Deerlin, Paul A. Yushkevich, Dawn Mechanic-Hamilton, Sharon X. Xie, Daniel T. Ohm, David A. Wolk, David J. Irwin, Jeffrey S. Phillips, Edward B. Lee

        • May 2, 2026

        Related Content

        Cedars-Sinai Advances Research That Could Aid Early Alzheimer’s Diagnosis

        Three recently published studies from Cedars-Sinai investigators have deepened knowledge of how changes in the eye are linked to indicators of Alzheimer’s disease in the brain.

        • by

        • August 28, 2024

        • 4 min
        Neurological manifestations in people with HIV in HAART era: a cross-sectional multicenter study

        The Retina: A Window on Neurodegeneration

        New evidence links Chlamydia pneumoniae to retinal inflammation patterns associated with neurodegeneration

        • March 9, 2026

        • 7 min